Developer of a novel implantable device designed to treat erectile dysfunction. Comphya is based in Lausanne, Switzerland. Its last reported valuation was $80.8 million in Jul 2025. It has raised $16.8 million.
Last reported valuation
$80.8M
Oct 2026
Priced at
—
Total raised
$16.8M
Last round
—
Team — not yet on record
No current team members for Comphya are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Comphya with a free account
·The complete investor list: 11 names
·Watch Comphya: the Monday email on marks, rounds and moves
